Expression and functional role of nitric oxide synthase isoforms in human osteoblast-like cells.

Previous studies have shown evidence of constitutive and cytokine-inducible nitric oxide (NO) synthase activity in cultured osteoblast-like cells from various species. Although cytokine-induced NO production has been found to inhibit osteoblast growth, the role of constitutive NO production in regulating osteoblast function is less clear and the isoforms of nitric oxide synthase (NOS) that are expressed by human osteoblasts have not been determined. Here, we investigated NOS expression in cultured human osteoblast-like cells and studied the effects of constitutive and cytokine-induced NO on osteoblast growth and differentiation. Low levels of NO were produced constitutively by osteoblast-like cells as reflected by analysis of medium nitrite concentrations, and evidence of ecNOS mRNA, protein, and bioactivity was found in primary osteoblasts (hOBs), TE85, and MG63 osteosarcoma cells. None of the osteoblast-like cells expressed nNOS, however, and iNOS was produced only by hOB cells after stimulation with the cytokines IL-1beta, TNF-alpha, and IFN-gamma. The NOS inhibitor, L-NMMA, did not affect growth or alkaline phosphatase activity in unstimulated osteoblasts. Incubation of hOB cells with cytokines inhibited growth and stimulated alkaline phosphatase activity and these effects were abrogated by L-NMMA. Cytokines also inhibited growth of TE85 cells and MG63 cells, but these effects appeared to be NO independent because they were not influenced by L-NMMA. Our experiments show that human osteoblasts constitutively produce NO through the ecNOS pathway, but demonstrate that this does not appear to exert an appreciable effect on osteoblast growth or differentiation under basal conditions. In contrast, IL-1beta, TNF-alpha, and IFN-gamma exerted growth-inhibiting and differentiation-inducing effects on osteoblasts that were partly NO dependent, indicating that NO may act predominantly as a modulator of cytokine-induced effects on osteoblast function.

[1]  C. Nathan,et al.  Nitric oxide as a secretory product of mammalian cells , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[3]  J. Poser,et al.  Human Bone Cells in Culture. A Novel System for the Investigation of Bone Cell Metabolism , 1983 .

[4]  A. Billiau,et al.  In vitro cultivation of human tumor tissues. II. Morphological and virological characterization of three cell lines. , 1978, Oncology.

[5]  J. Pollock,et al.  Expression of Nitric Oxide Synthase Isoforms in Bone and Bone Cell Cultures , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  P. Nijweide,et al.  Pulsating fluid flow increases nitric oxide (NO) synthesis by osteocytes but not periosteal fibroblasts--correlation with prostaglandin upregulation. , 1995, Biochemical and biophysical research communications.

[7]  M. Salter,et al.  Widespread tissue distribution, species distribution and changes in activity of Ca2+‐dependent and Ca2+‐independent nitric oxide synthases , 1991, FEBS letters.

[8]  J. Polak,et al.  Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. , 1995, Endocrinology.

[9]  P. Hauschka,et al.  Cytokines induce nitric oxide production in mouse osteoblasts. , 1994, Biochemical and biophysical research communications.

[10]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[11]  S. Ralston,et al.  Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. , 1994, Endocrinology.

[12]  E H Burger,et al.  Nitric oxide response to shear stress by human bone cell cultures is endothelial nitric oxide synthase dependent. , 1998, Biochemical and biophysical research communications.

[13]  J. Riancho,et al.  Mechanisms controlling nitric oxide synthesis in osteoblasts , 1995, Molecular and Cellular Endocrinology.

[14]  J. Weinberg,et al.  Differential effects of nitric oxide on erythroid and myeloid colony growth from CD34+ human bone marrow cells. , 1996, Blood.

[15]  F. Murad,et al.  Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies. , 1993, The American journal of physiology.

[16]  G. Wesolowski,et al.  Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. , 1987, Cancer research.

[17]  C. Bradt,et al.  Cultivation in vitro of cells derived from a human osteosarcoma , 1971, Cancer.

[18]  P. Nibbering,et al.  Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. , 1994, The Journal of clinical investigation.

[19]  J. Pontén,et al.  Two established in vitro cell lines from human mesenchymal tumours , 1967, International journal of cancer.

[20]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[21]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[22]  H. Bartsch,et al.  Immunohistochemical localization of an inducible form of nitric oxide synthase in various organs of rats treated with Propionibacterium acnes and lipopolysaccharide , 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[23]  S. Ralston,et al.  Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells. , 1998, Endocrinology.

[24]  S. Ralston,et al.  Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. , 1997, British journal of rheumatology.

[25]  P. W. Johnston,et al.  Nitric oxide: A cytokine‐induced regulator of bone resorption , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  P. Damoulis,et al.  Nitric Oxide Acts in Conjunction with Proinflammatory Cytokines to Promote Cell Death in Osteoblasts , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  V. Robert,et al.  Metabolism of L-arginine through polyamine and nitric oxide synthase pathways in proliferative or differentiated human colon carcinoma cells. , 1995, Biochimica et biophysica acta.

[28]  T. Sugimura,et al.  Polyclonal antibody against an inducible form of nitric oxide synthase purified from the liver of rats treated with Propionibacterium acnes and lipopolysaccharide. , 1992, Biochemical and biophysical research communications.

[29]  S. Ralston,et al.  Cytokine‐Induced Nitric Oxide Inhibits Bone Resorption by Inducing Apoptosis of Osteoclast Progenitors and Suppressing Osteoclast Activity , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  A. Billiau,et al.  In vitro cultivation of human tumor tissues. , 1975, Oncology.

[31]  J. Poser,et al.  Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids. , 1984, Metabolic bone disease & related research.

[32]  J. Riancho,et al.  Expression and functional role of nitric oxide synthase in osteoblast‐like cells , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.